Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.25 AUD
16.28%
Market Closed
Updated:
May 14, 2024
Somnomed Ltd
Gross Profit
|
Somnomed Ltd
Gross Profit Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Gross Profit
AU$54.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
|
ImpediMed Ltd
ASX:IPD
|
Gross Profit
AU$9.1m
|
CAGR 3-Years
24%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Gross Profit
AU$17.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Cochlear Ltd
ASX:COH
|
Gross Profit
AU$1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Gross Profit
AU$2.5m
|
CAGR 3-Years
223%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Gross Profit?
Gross Profit
54.8m
AUD
54.8m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Gross Profit amounts to 54.8m AUD.
What is Somnomed Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%
14%
Over the last year, the Gross Profit growth was 13%. The average annual Gross Profit growth rates for Somnomed Ltd have been 20% over the past three years , 9% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
